Covid testing lifts profit for pathology provider
APHG, now part owned by the Super Fund, reports profit up 17%.
APHG, now part owned by the Super Fund, reports profit up 17%.
Pathology group APHG has posted a bumper profit for the year to December, boosted by its major role in providing Covid-19 tests.
Net profit for the year was $40.4 million from revenue of $307.7m, up from $34.4m and $264.3m respectively in the year to June 2019 before a change of balance
Want to read more? It's easy.
Choose your best value subscription option
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly
credit card debit
Yearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login